PHENERGAN

This brand name is authorized in United States. It is also authorized in France, Ireland, Israel, Malta, New Zealand, Tunisia, UK.

Active ingredients

The drug PHENERGAN contains one active pharmaceutical ingredient (API):

1	Promethazine UNII R61ZEH7I1I - PROMETHAZINE HYDROCHLORIDE
	Promethazine is a potent, long acting, antihistamine with additional anti-emetic central sedative and anti-cholinergic properties.
	Read more about Promethazine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
PHENERGAN Solution for injection	MPI, US: SPL/Old	FDA, National Drug Code (US)
PHENERGAN Solution for injection	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D04AA10	Promethazine	D Dermatologicals → D04 Antipruritics, incl. antihistamines, anesthetics, etc. → D04A Antipruritics, incl. antihistamines, anesthetics, etc. → D04AA Antihistamines for topical use
Discover more medicines within D04AA10
R06AD02	Promethazine	R Respiratory system → R06 Antihistamines for systemic use → R06A Antihistamines for systemic use → R06AD Phenothiazine derivatives
Discover more medicines within R06AD02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
FR	Base de données publique des médicaments	68921769, 69646945, 69764032
GB	Medicines & Healthcare Products Regulatory Agency	198590, 23555, 23574, 23575, 23576, 27816
IE	Health Products Regulatory Authority	40584, 40606
IL	מִשְׂרַד הַבְּרִיאוּת	8816
MT	Medicines Authority	AA565/17103, AA908/20101
NZ	Medicines and Medical Devices Safety Authority	2335, 2342
TN	Direction de la Pharmacie et du Médicament	9253701, 9253702
US	FDA, National Drug Code	0641-6082, 0641-6083, 0641-6084, 0641-6085, 61919-396, 70518-2656